2Fabrizi F,Martin P,Bunnapradist S,et al.Lamivudinein the treat ment of HBV-related liver disease after renal transplantation:an update[].International Journal of Artificial Organs.2005
3Gong ZJ,De Meyer S,Clarysse C,et al.Mycophenolic acid,an immunosuppressive agent, inhibits HBV replication in vitro[].Journal of Viral Hepatitis.1999
4Wu J,Xie HY,Jiang GP,Xu X,Zheng SS.The effect of mycophenolate acid on hepatitis B virus replication in vitro[].Journal of Hepatobiliary Pancreat Disease.2003
5Ying C,De Clercq E,Neyts J.Ribavirin and mycophenolic acid potentiate the activity of guanine-and diaminopurine-based nucleoside analogues against hepatitis B virus.Antiviral Res,2000,48(2):117 ～ 124.
6Fabrizi F,Martin P,Bunnapradist S,et al.Lamivudine in the treatment of HBV-related liver disease afte renal transplantation:an update.Int J Artif Organs,2005,28(3):211 ～ 221.
7Deeren DH,De Backer AI,Malbrain ML,et al.Treatment of hepatitis B virus-related polyarteritis nodosa:two case repoats and a review of the literature.Clin Rheumatol,2004,23:172 ～ 176.
8Akuta N,Kumada H.Influence of hepatitis B virus genotypes on the response to sntiviral therapies.J Antimicrob hemother,2005,55(2):139～ 142.
9Arosemena LR,Cortes RA,Servin L,Schiff ER.Current and future treatment of chronic hepatitis B.Minerva Gastroenterol Dietol,2005,51 (1):77 ～ 93.
10Vassiliadis T,Garipidou V,Tziomalos K,et al.Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy-a prospective case series.Am J Hematol,2005,80:197 ～ 203.
3Allison AC,Eugui EM. Mycophenolate acid and brequinar,inhibitors of purine and pyrimidine synthesis,block the glycosylation of adhesion molecules[J].Immunopharmacology,2000,(03):85-88.
4Aragon E,Chan YH,Ng KH. Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis[J].Lupus,2010,(08):965-973.
5Touma Z,Gladman DD,Urowitz MB. Mycophenolate mofetil for induction treatment of lupus nephritis:a systematic review and meta analysis[J].Journal of Rheumatology,2011,(01):69-78.
6Houssiau FA,Cruz D,Sangle S. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis:results from the maintain nephritis trial[J].Annals of the Rheumatic Diseases,2010,(12):2083-2089.
7Laskari K,Mavragani CP,Tzioufas AG. Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis:a long-term observational prospective study[J].Arthritis Research & Therapy,2010,(06):208.
8Ginzler EM,Wofsy D,Isenberg D. Nonrenal disease activity following mycophenolate mofetil orintravenous cyclophosphamide as induction treatment for lupus nephritis[J].Arthritis and Rheumatism,2010,(01):211-222.
